Patient profiles as drivers of physician choice for first-line (1L) treatment (tx) in locally advanced or metastatic urothelial cancer (la/mUC): Perspectives from a US study.
| Publicado en: | Journal of Clinical Oncology Vol. 43; pp. 719 - 961 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/10/2025 Supplement5
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184084939&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184084939 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2/10/2025 Supplement5 vid: 43 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 184084939 10.1200/JCO.2025.43.5_suppl.719 184084939 ppf: 719 ppct: 242 formats: tig: atl: Patient profiles as drivers of physician choice for first-line (1L) treatment (tx) in locally advanced or metastatic urothelial cancer (la/mUC): Perspectives from a US study. aug: au: Milloy, Neil Walley, Maria Simpson, Amber Forshaw, Cameron Morris, Valerie A. Kearney, Mairead affil: Adelphi Real World, Bollington, United Kingdom sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|